220 related articles for article (PubMed ID: 19250717)
1. Homology modeling of MCH1 receptor and validation by docking/scoring and protein-aligned CoMFA.
Abu-Hammad A; Zalloum WA; Zalloum H; Abu-Sheikha G; Taha MO
Eur J Med Chem; 2009 Jun; 44(6):2583-96. PubMed ID: 19250717
[TBL] [Abstract][Full Text] [Related]
2. Combining docking, scoring and molecular field analyses to probe influenza neuraminidase-ligand interactions.
Abu Hammad AM; Afifi FU; Taha MO
J Mol Graph Model; 2007 Sep; 26(2):443-56. PubMed ID: 17360207
[TBL] [Abstract][Full Text] [Related]
3. Effects of variable docking conditions and scoring functions on corresponding protein-aligned comparative molecular field analysis models constructed from diverse human protein tyrosine phosphatase 1B inhibitors.
Taha MO; AlDamen MA
J Med Chem; 2005 Dec; 48(25):8016-34. PubMed ID: 16335926
[TBL] [Abstract][Full Text] [Related]
4. Modeling ligand-receptor interaction for some MHC class II HLA-DR4 peptide mimetic inhibitors using several molecular docking and 3D QSAR techniques.
Wei HY; Tsai KC; Lin TH
J Chem Inf Model; 2005; 45(5):1343-51. PubMed ID: 16180911
[TBL] [Abstract][Full Text] [Related]
5. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
[TBL] [Abstract][Full Text] [Related]
6. Consensus adaptation of fields for molecular comparison (AFMoC) models incorporate ligand and receptor conformational variability into tailor-made scoring functions.
Breu B; Silber K; Gohlke H
J Chem Inf Model; 2007; 47(6):2383-400. PubMed ID: 17958410
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel chemotypes to a G-protein-coupled receptor through ligand-steered homology modeling and structure-based virtual screening.
Cavasotto CN; Orry AJ; Murgolo NJ; Czarniecki MF; Kocsi SA; Hawes BE; O'Neill KA; Hine H; Burton MS; Voigt JH; Abagyan RA; Bayne ML; Monsma FJ
J Med Chem; 2008 Feb; 51(3):581-8. PubMed ID: 18198821
[TBL] [Abstract][Full Text] [Related]
8. CoMFA and molecular docking studies of benzoxazoles and benzothiazoles as CYP450 1A1 inhibitors.
Pan J; Liu GY; Cheng J; Chen XJ; Ju XL
Eur J Med Chem; 2010 Mar; 45(3):967-72. PubMed ID: 19969397
[TBL] [Abstract][Full Text] [Related]
9. Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols.
Evers A; Hessler G; Matter H; Klabunde T
J Med Chem; 2005 Aug; 48(17):5448-65. PubMed ID: 16107144
[TBL] [Abstract][Full Text] [Related]
10. Combined 3D-QSAR modeling and molecular docking study on indolinone derivatives as inhibitors of 3-phosphoinositide-dependent protein kinase-1.
AbdulHameed MD; Hamza A; Liu J; Zhan CG
J Chem Inf Model; 2008 Sep; 48(9):1760-72. PubMed ID: 18717540
[TBL] [Abstract][Full Text] [Related]
11. Development and evaluation of a generic evolutionary method for protein-ligand docking.
Yang JM
J Comput Chem; 2004 Apr; 25(6):843-57. PubMed ID: 15011256
[TBL] [Abstract][Full Text] [Related]
12. SitePrint: three-dimensional pharmacophore descriptors derived from protein binding sites for family based active site analysis, classification, and drug design.
Arnold JR; Burdick KW; Pegg SC; Toba S; Lamb ML; Kuntz ID
J Chem Inf Comput Sci; 2004; 44(6):2190-8. PubMed ID: 15554689
[TBL] [Abstract][Full Text] [Related]
13. Towards a MIP-based alignment and docking in computer-aided drug design.
Barbany M; Gutiérrez-de-Terán H; Sanz F; Villà-Freixa J
Proteins; 2004 Aug; 56(3):585-94. PubMed ID: 15229890
[TBL] [Abstract][Full Text] [Related]
14. Comparative assessment of scoring functions on a diverse test set.
Cheng T; Li X; Li Y; Liu Z; Wang R
J Chem Inf Model; 2009 Apr; 49(4):1079-93. PubMed ID: 19358517
[TBL] [Abstract][Full Text] [Related]
15. Towards in silico lead optimization: scores from ensembles of protein/ligand conformations reliably correlate with biological activity.
Popov VM; Yee WA; Anderson AC
Proteins; 2007 Feb; 66(2):375-87. PubMed ID: 17078091
[TBL] [Abstract][Full Text] [Related]
16. A scoring function for docking ligands to low-resolution protein structures.
Bindewald E; Skolnick J
J Comput Chem; 2005 Mar; 26(4):374-83. PubMed ID: 15651033
[TBL] [Abstract][Full Text] [Related]
17. The use of three-dimensional shape and electrostatic similarity searching in the identification of a melanin-concentrating hormone receptor 1 antagonist.
Muchmore SW; Souers AJ; Akritopoulou-Zanze I
Chem Biol Drug Des; 2006 Feb; 67(2):174-6. PubMed ID: 16492165
[TBL] [Abstract][Full Text] [Related]
18. 6-Acylamino-2-aminoquinolines as potent melanin-concentrating hormone 1 receptor antagonists. Identification, structure-activity relationship, and investigation of binding mode.
Ulven T; Frimurer TM; Receveur JM; Little PB; Rist O; Nørregaard PK; Högberg T
J Med Chem; 2005 Sep; 48(18):5684-97. PubMed ID: 16134937
[TBL] [Abstract][Full Text] [Related]
19. The consequences of scoring docked ligand conformations using free energy correlations.
Spyrakis F; Amadasi A; Fornabaio M; Abraham DJ; Mozzarelli A; Kellogg GE; Cozzini P
Eur J Med Chem; 2007 Jul; 42(7):921-33. PubMed ID: 17346861
[TBL] [Abstract][Full Text] [Related]
20. Molecular docking for substrate identification: the short-chain dehydrogenases/reductases.
Favia AD; Nobeli I; Glaser F; Thornton JM
J Mol Biol; 2008 Jan; 375(3):855-74. PubMed ID: 18036612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
